Skip to main content

Reliability of heterophyid antigens in heterologous protection against human schistosomiasis

Research Abstract
Schistosomiasis is a neglected tropical parasitic disease which has been controlled by praziquantel for many decades; however, reemergence of praziquantel resistant strains has been a continuous threat. Therefore, the development of reliable antischistosomal vaccine is significantly demanded for optimal control. In the present study, comparison among Schistosoma haematobium, Schsitosoma mansoni and Pygidiopsis genata crude antigens was carried out by Sodium dodecyl sulphate polyacrylamide gel electrophoresis. Hyperimmunization of rabbits with tested parasites’ crude antigens was done to obtain hyperimmune sera. Western blotting was applied to show cross reactivity between parasites’ crude antigens and either homologous or heterologous sera. Although there was no cross reaction between P. genata crude antigens and sera of both Schistosoma species and vice versa; it is supposed that the immunogenic band at 79 kDa might develop cross reactivity with Schistosma spp. SEA fractionation if used in future studies.
Research Authors
Alaa H. A., Hegazy, Lamia A., Galal, Refaat M. A., Khalifa.
Research Department
Research Journal
Journal of Parasitic diseases (JOPD)
Research Pages
349–354
Research Publisher
NULL
Research Rank
1
Research Vol
44
Research Website
Springer link
Research Year
2020

Stress hyperglycemia and electrolytes disturbance in patients with acute cerebrovascular stroke

Research Abstract
Abstract Background: Stroke is a medical emergency and considered the 2nd leading cause of mortality worldwide. High morbidity and mortality of stroke are due to some complications like cerebral edema, infection, and associated heart disease. Stroke may cause stress hyperglycemia and electrolyte disturbance that may be independent predictors for increased morbidity and mortality. Data on electrolyte disorder in neurological conditions especially acute stroke are somewhat scanty and not frequently interpreted. Objectives: The current study aimed to evaluate the effect of stress induced by acute stroke on the blood glucose and serum electrolytes and its relationship to the type, severity, and prognosis of stroke. Subjects and methods: A total of 100 patients admitted with acute stroke were included in the study. After informed consent, fasting blood sugar, glycosylated hemoglobin, serum sodium, and potassium levels were measured simultaneously. Stroke severity and outcome were assessed using the Glasgow Coma Scale. Results: Stress hyperglycemia was noted in 21 patients, out of which 62% presented with hemorrhagic stroke. Undiagnosed diabetes was found in 47% of cases. Also, 13 % of our patients had both stress hyperglycemia and electrolyte disturbance simultaneously. Mortality among hemorrhagic versus ischemic patients was 46% and 22%, respectively. The independent predictors of mortality were stress hyperglycemia, electrolytes disturbance, ischemic heart diseases, and type and admission severity of stroke. Conclusion: Stress hyperglycemia and electrolyte disturbance after acute stroke were found in 21% and 47% of patients respectively and may adversely affect outcome of stroke especially those with cerebral hemorrhage.
Research Authors
Bastawy M. El-Fawal, Reda Badry, Wael A. Abbas and Ahmed K. Ibrahim
Research Department
Research Journal
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
Research Member
Research Pages
https://doi.org/10.1186/s41983-019-0137-0
Research Publisher
Springer
Research Rank
1
Research Vol
55:86
Research Website
https://ejnpn.springeropen.com/articles/10.1186/s41983-019-0137-0
Research Year
2019

Stress hyperglycemia and electrolytes disturbance in patients with acute cerebrovascular stroke

Research Abstract
Abstract Background: Stroke is a medical emergency and considered the 2nd leading cause of mortality worldwide. High morbidity and mortality of stroke are due to some complications like cerebral edema, infection, and associated heart disease. Stroke may cause stress hyperglycemia and electrolyte disturbance that may be independent predictors for increased morbidity and mortality. Data on electrolyte disorder in neurological conditions especially acute stroke are somewhat scanty and not frequently interpreted. Objectives: The current study aimed to evaluate the effect of stress induced by acute stroke on the blood glucose and serum electrolytes and its relationship to the type, severity, and prognosis of stroke. Subjects and methods: A total of 100 patients admitted with acute stroke were included in the study. After informed consent, fasting blood sugar, glycosylated hemoglobin, serum sodium, and potassium levels were measured simultaneously. Stroke severity and outcome were assessed using the Glasgow Coma Scale. Results: Stress hyperglycemia was noted in 21 patients, out of which 62% presented with hemorrhagic stroke. Undiagnosed diabetes was found in 47% of cases. Also, 13 % of our patients had both stress hyperglycemia and electrolyte disturbance simultaneously. Mortality among hemorrhagic versus ischemic patients was 46% and 22%, respectively. The independent predictors of mortality were stress hyperglycemia, electrolytes disturbance, ischemic heart diseases, and type and admission severity of stroke. Conclusion: Stress hyperglycemia and electrolyte disturbance after acute stroke were found in 21% and 47% of patients respectively and may adversely affect outcome of stroke especially those with cerebral hemorrhage.
Research Authors
Bastawy M. El-Fawal, Reda Badry, Wael A. Abbas and Ahmed K. Ibrahim
Research Journal
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
Research Pages
https://doi.org/10.1186/s41983-019-0137-0
Research Publisher
Springer
Research Rank
1
Research Vol
55:86
Research Website
https://ejnpn.springeropen.com/articles/10.1186/s41983-019-0137-0
Research Year
2019

Stress hyperglycemia and electrolytes disturbance in patients with acute cerebrovascular stroke

Research Abstract
Abstract Background: Stroke is a medical emergency and considered the 2nd leading cause of mortality worldwide. High morbidity and mortality of stroke are due to some complications like cerebral edema, infection, and associated heart disease. Stroke may cause stress hyperglycemia and electrolyte disturbance that may be independent predictors for increased morbidity and mortality. Data on electrolyte disorder in neurological conditions especially acute stroke are somewhat scanty and not frequently interpreted. Objectives: The current study aimed to evaluate the effect of stress induced by acute stroke on the blood glucose and serum electrolytes and its relationship to the type, severity, and prognosis of stroke. Subjects and methods: A total of 100 patients admitted with acute stroke were included in the study. After informed consent, fasting blood sugar, glycosylated hemoglobin, serum sodium, and potassium levels were measured simultaneously. Stroke severity and outcome were assessed using the Glasgow Coma Scale. Results: Stress hyperglycemia was noted in 21 patients, out of which 62% presented with hemorrhagic stroke. Undiagnosed diabetes was found in 47% of cases. Also, 13 % of our patients had both stress hyperglycemia and electrolyte disturbance simultaneously. Mortality among hemorrhagic versus ischemic patients was 46% and 22%, respectively. The independent predictors of mortality were stress hyperglycemia, electrolytes disturbance, ischemic heart diseases, and type and admission severity of stroke. Conclusion: Stress hyperglycemia and electrolyte disturbance after acute stroke were found in 21% and 47% of patients respectively and may adversely affect outcome of stroke especially those with cerebral hemorrhage.
Research Authors
Bastawy M. El-Fawal, Reda Badry, Wael A. Abbas and Ahmed K. Ibrahim
Research Journal
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
Research Pages
https://doi.org/10.1186/s41983-019-0137-0
Research Publisher
Springer
Research Rank
1
Research Vol
55:86
Research Website
https://ejnpn.springeropen.com/articles/10.1186/s41983-019-0137-0
Research Year
2019

Correlation between initial tumour volume and treatment duration on Dabrafenib: observation study of subjects with BRAF mutant melanoma on the BRF112680 trial

Research Abstract
Abstract Background: Planar-based measurements of lesions in metastatic melanoma have limitations in estimating tumor burden of a patient and in predicting response to treatment. Volumetric imaging might add predictive value to Response criteria in Solid Tumor (RECIST)-measurement. Based on clinical observations, we explored the association between baseline tumor volume (TV) and duration of treatment with dabrafenib in patients with metastatic melanoma. We have also explored the prognostic value of TV for overall survival (OS) and progression free survival (PFS). Methods: This is a retrospective, chart-review of primary source documents and medical imaging of a cohort of patients participating in the BRF112680 phase 1 clinical trial at the Prince of Wales Hospital. TV was quantified by contouring all the measurable baseline target lesions in the standard manner for radiation planning using Voxxar™ software. We used Cox regression models to analyse associations between TV and duration of treatment with dabrafenib and between TV, PFS and OS. Results: Among 13 patients of BRAF 112680 trial, 10 were included in the retrospective analysis. Target lesion sum volume ranged from 0.3 to 1065.5 cm3 (cc), with a median of 27.5 cc. The median PFS and OS were 420 days (range 109–1765) and 1680 days (range 390–2940), respectively. The initial TV was inversely correlated with duration of treatment with dabrafenib (rho − 0.6; P 0.03). In multivariate analysis, TV was a predictor for OS (HR 2.81 CI 1.06– 6.19) and PFS (8.76 (CI 1.05–43.58). Patients with tumour volume above the median had significantly lower OS of 6- months compared to 56-months survival for patients with smaller volumes; P = 0.019. Conclusions: TV is a predictor for treatment duration and is prognostic of OS and PFS in patients with metastatic melanoma. These findings need to be validated prospectively in clinical trials
Research Authors
Arwa Ali, Monica Dumbrava, Kylie Ridde, Nina Stewart, Robyn Ward, Ahmed K. Ibrahim and Melvin Chin
Research Journal
BMC cancer
Research Pages
NULL
Research Publisher
Springer Nature
Research Rank
1
Research Vol
20:342
Research Website
https://bmccancer.biomedcentral.com/articles/10.1186/s12885-020-06848-8
Research Year
2020

Correlation between initial tumour volume and treatment duration on Dabrafenib: observation study of subjects with BRAF mutant melanoma on the BRF112680 trial

Research Abstract
Abstract Background: Planar-based measurements of lesions in metastatic melanoma have limitations in estimating tumor burden of a patient and in predicting response to treatment. Volumetric imaging might add predictive value to Response criteria in Solid Tumor (RECIST)-measurement. Based on clinical observations, we explored the association between baseline tumor volume (TV) and duration of treatment with dabrafenib in patients with metastatic melanoma. We have also explored the prognostic value of TV for overall survival (OS) and progression free survival (PFS). Methods: This is a retrospective, chart-review of primary source documents and medical imaging of a cohort of patients participating in the BRF112680 phase 1 clinical trial at the Prince of Wales Hospital. TV was quantified by contouring all the measurable baseline target lesions in the standard manner for radiation planning using Voxxar™ software. We used Cox regression models to analyse associations between TV and duration of treatment with dabrafenib and between TV, PFS and OS. Results: Among 13 patients of BRAF 112680 trial, 10 were included in the retrospective analysis. Target lesion sum volume ranged from 0.3 to 1065.5 cm3 (cc), with a median of 27.5 cc. The median PFS and OS were 420 days (range 109–1765) and 1680 days (range 390–2940), respectively. The initial TV was inversely correlated with duration of treatment with dabrafenib (rho − 0.6; P 0.03). In multivariate analysis, TV was a predictor for OS (HR 2.81 CI 1.06– 6.19) and PFS (8.76 (CI 1.05–43.58). Patients with tumour volume above the median had significantly lower OS of 6- months compared to 56-months survival for patients with smaller volumes; P = 0.019. Conclusions: TV is a predictor for treatment duration and is prognostic of OS and PFS in patients with metastatic melanoma. These findings need to be validated prospectively in clinical trials
Research Authors
Arwa Ali, Monica Dumbrava, Kylie Ridde, Nina Stewart, Robyn Ward, Ahmed K. Ibrahim and Melvin Chin
Research Journal
BMC cancer
Research Pages
NULL
Research Publisher
Springer Nature
Research Rank
1
Research Vol
20:342
Research Website
https://bmccancer.biomedcentral.com/articles/10.1186/s12885-020-06848-8
Research Year
2020

Transvenous pulmonary chemoembolization (TPCE) for palliative or neoadjuvant treatment of lung metastases

Research Abstract
NULL
Research Authors
Thomas J. Vogl1 & Ahmed I. A. Mekkawy1,2 & Duaa B. Thabet3 & Mostafa El-Sharkaway2 & Hosam M. Kamel2 &
Moritz H. Albrecht1 & Nagy N. N. Naguib1,4 & Afaf Hassan5
Research Journal
European
Research Pages
NULL
Research Publisher
NULL
Research Rank
1
Research Vol
NULL
Research Website
NULL
Research Year
2018

Transvenous pulmonary chemoembolization (TPCE) for palliative or neoadjuvant treatment of lung metastases

Research Abstract
NULL
Research Authors
Thomas J. Vogl1 & Ahmed I. A. Mekkawy1,2 & Duaa B. Thabet3 & Mostafa El-Sharkaway2 & Hosam M. Kamel2 &
Moritz H. Albrecht1 & Nagy N. N. Naguib1,4 & Afaf Hassan5
Research Journal
European
Research Pages
NULL
Research Publisher
NULL
Research Rank
1
Research Vol
NULL
Research Website
NULL
Research Year
2018

Transvenous pulmonary chemoembolization (TPCE) for palliative or neoadjuvant treatment of lung metastases

Research Abstract
NULL
Research Authors
Thomas J. Vogl1 & Ahmed I. A. Mekkawy1,2 & Duaa B. Thabet3 & Mostafa El-Sharkaway2 & Hosam M. Kamel2 &
Moritz H. Albrecht1 & Nagy N. N. Naguib1,4 & Afaf Hassan5
Research Journal
European
Research Pages
NULL
Research Publisher
NULL
Research Rank
1
Research Vol
NULL
Research Website
NULL
Research Year
2018

Transvenous pulmonary chemoembolization (TPCE) for palliative or neoadjuvant treatment of lung metastases

Research Abstract
NULL
Research Authors
Thomas J. Vogl1 & Ahmed I. A. Mekkawy1,2 & Duaa B. Thabet3 & Mostafa El-Sharkaway2 & Hosam M. Kamel2 &
Moritz H. Albrecht1 & Nagy N. N. Naguib1,4 & Afaf Hassan5
Research Journal
European
Research Pages
NULL
Research Publisher
NULL
Research Rank
1
Research Vol
NULL
Research Website
NULL
Research Year
2018
Subscribe to